Title : Assessment of the Effects of Inhibition or Induction of CYP2C19 and CYP2C9 Enzymes, or Inhibition of OAT3, on the Pharmacokinetics of Abrocitinib and Its Metabolites in Healthy Individuals.

Pub. Date : 2022 May

PMID : 35226304






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The OAT3 inhibitor probenecid increased the AUCinf of the unbound active moiety by 66%. Probenecid solute carrier family 22 member 8 Homo sapiens